APP substrate ectodomain defines A beta length by restraining gamma-secretase processivity and facilitating product release

Sequential proteolysis of the amyloid precursor protein (APP) by {gamma}-secretases (GSECs) generates amyloid-{beta} (A{beta}) and defines the proportion of short-to-long A{beta} peptides, which is tightly connected to Alzheimers disease (AD) pathogenesis. Here, we study the mechanism controlling substrate processing by GSECs and defining product length. We found that polar interactions established by the APPC99 ectodomain (ECD), involving but not limited to its juxtamembrane region, restrain both the extent and degree of GSEC processive cleavage by destabilizing enzyme-substrate (E-S) interactions. We show that increasing hydrophobicity at APPC99-ECD - due to mutation or ligand binding - attenuates this substrate-driven product release mechanism, and rescues the effects that AD pathogenic variants exert on A{beta} profiles. In addition, our study reveals that APPC99-ECD facilitates the paradoxical production of longer A{beta}s caused by some GSEC inhibitors that act as high-affinity competitors to the substrate. These findings assign a pivotal role to the substrate ECD in the sequential proteolysis by GSEC and suggest it as a sweet spot for the potential design of APP targeting compounds selectively promoting its processing by GSEC.